Cargando…

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19

Detalles Bibliográficos
Autores principales:	Pessoa-Amorim, Guilherme, Mafham, Marion M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Cardiovascular Research Onlife
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318096/ https://www.ncbi.nlm.nih.gov/pubmed/34320164 http://dx.doi.org/10.1093/cvr/cvab239

Ejemplares similares

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020)

ISCHEMIA: new questions from a landmark trial
por: Morrow, Andrew, et al.
Publicado: (2020)

Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
por: Guzik, Tomasz J
Publicado: (2017)

Up in the air: links between the environment and cardiovascular disease
por: Münzel, Thomas
Publicado: (2019)

Cardiovascular disease in transgender people: recent research and emerging evidence
por: Connelly, Paul J, et al.
Publicado: (2021)

The curious case of dermal fibroblasts: cell identity loss may be a mechanism underlying cardiovascular aging
por: Badi, Ileana
Publicado: (2019)

Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
por: Smeda, Marta, et al.
Publicado: (2020)

Therapeutic gene editing, making a point
por: Smits, Anke M
Publicado: (2019)

The epitranscriptome: tools to study, manipulate, and exploit RNA modifications
por: Nossent, Anne Yaël
Publicado: (2019)

Highlights of American Heart Association Scientific Sessions 2020: a virtual experience
por: Adão, Rui, et al.
Publicado: (2021)

Atrial fibrillation after cardiac surgery: to screen or not to screen?
por: Casadei, Barbara, et al.
Publicado: (2021)

Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2021)

New understanding of circulatory blood flow and arterial blood pressure mechanisms
por: Wolff, Christopher Bancroft, et al.
Publicado: (2022)

Limitations of the glycaemic index and the need for nuance when determining carbohydrate quality
por: Kanter, Mitch, et al.
Publicado: (2021)

The post-pandemic legacy: the breakthrough of digital health and telemedicine
por: Bruining, Nico
Publicado: (2021)

Scientists on the Spot: The complex inheritance of cardiac disorders
por: Patel, Jyoti, et al.
Publicado: (2019)

What to expect from drug targeting factor XI?
por: Nagy, Magdolna, et al.
Publicado: (2022)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

Azithromycin, RECOVERY, and the power of large, simple trials
por: Berwanger, Otavio
Publicado: (2021)

Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study
por: Mafham, Marion M., et al.
Publicado: (2019)

What is the association of COVID-19 with heart attacks and strokes?
por: Mafham, Marion, et al.
Publicado: (2021)

Editorial: What do we know about COVID-19 implications for cardiovascular disease?
por: Wang, Zeyuan, et al.
Publicado: (2023)

SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhao, Zinan, et al.
Publicado: (2022)

Methodological Quality and Risk of Bias Assessment of Cardiovascular Disease Research: Analysis of Randomized Controlled Trials Published in 2017
por: Baasan, Odgerel, et al.
Publicado: (2022)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
por: Bowman, Louise, et al.
Publicado: (2018)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
por: Parish, Sarah, et al.
Publicado: (2023)

OR21-4 Heart Health 4 Moms: A Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia
por: Seely, Ellen, et al.
Publicado: (2019)

ODP154 Reduction of Cardiac Adipose Tissue Volume with Short-Term Empagliflozin in Patients with Type 2 Diabetes: Results from the SIMPLE Randomized Clinical Trial
por: Brandt-Jacobsen, Niels, et al.
Publicado: (2022)

Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
por: Cho, Jae Young, et al.
Publicado: (2023)

Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
por: Tornyos, Dániel, et al.
Publicado: (2022)

Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006–2015
por: Baldi, Ileana, et al.
Publicado: (2017)

Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19
por: Law, Ching Chee, et al.
Publicado: (2021)

Randomized trial of red cell washing for the prevention of transfusion-associated organ injury in cardiac surgery
por: Woźniak, M. J., et al.
Publicado: (2017)

Cardiovascular Complications of COVID-19 Vaccines
por: Liu, Runyu, et al.
Publicado: (2022)

COVID-19 is associated with the risk of cardiovascular disease death: A two-sample Mendelian randomization study
por: Miao, Jia-peng, et al.
Publicado: (2022)

Long-Term Effect of Salt Substitute on All-Cause and Cardiovascular Disease Mortality: An Exploratory Follow-Up of a Randomized Controlled Trial
por: Sun, Hao, et al.
Publicado: (2021)

Effects and safety of Chinese herbal medicine on inflammatory biomarkers in cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
por: Li, Mingdi, et al.
Publicado: (2022)

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials
por: Gong, Chen, et al.
Publicado: (2022)

Patients’ motivations for participating in cardiovascular clinical trials: a local perspective
por: Burgess, LJ, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nd8va225jjphbkqo0nrom1cju9